• Something wrong with this record ?

Cellular transformation promotes the incorporation of docosahexaenoic acid into the endolysosome-specific lipid bis(monoacylglycerol)phosphate in breast cancer

AL. Berg, MR. Showalter, N. Kosaisawe, M. Hu, NC. Stephens, M. Sa, H. Heil, N. Castro, JJ. Chen, K. VanderVorst, MR. Wheeler, Z. Rabow, T. Cajka, J. Albeck, O. Fiehn, KL. Carraway

. 2023 ; 557 (-) : 216090. [pub] 20230210

Language English Country Ireland

Document type Journal Article, Research Support, N.I.H., Extramural

Bis(monoacylglycero)phosphates (BMPs), a class of lipids highly enriched within endolysosomal organelles, are key components of the lysosomal intraluminal vesicles responsible for activating sphingolipid catabolic enzymes. While BMPs are understudied relative to other phospholipids, recent reports associate BMP dysregulation with a variety of pathological states including neurodegenerative diseases and lysosomal storage disorders. Since the dramatic lysosomal remodeling characteristic of cellular transformation could impact BMP abundance and function, we employed untargeted lipidomics approaches to identify and quantify BMP species in several in vitro and in vivo models of breast cancer and comparative non-transformed cells and tissues. We observed lower BMP levels within transformed cells relative to normal cells, and consistent enrichment of docosahexaenoic acid (22:6) fatty acyl chain-containing BMP species in both human- and mouse-derived mammary tumorigenesis models. Our functional analysis points to a working model whereby 22:6 BMPs serve as reactive oxygen species scavengers in tumor cells, protecting lysosomes from oxidant-induced lysosomal membrane permeabilization. Our findings suggest that breast tumor cells might divert polyunsaturated fatty acids into BMP lipids as part of an adaptive response to protect their lysosomes from elevated reactive oxygen species levels, and raise the possibility that BMP-mediated lysosomal protection is a tumor-specific vulnerability that may be exploited therapeutically.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23003736
003      
CZ-PrNML
005      
20230425140842.0
007      
ta
008      
230418s2023 ie f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.canlet.2023.216090 $2 doi
035    __
$a (PubMed)36773796
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ie
100    1_
$a Berg, Anastasia L $u Department of Biochemistry and Molecular Medicine and UC Davis Comprehensive Cancer Center, University of California Davis School of Medicine, Sacramento, CA, USA
245    10
$a Cellular transformation promotes the incorporation of docosahexaenoic acid into the endolysosome-specific lipid bis(monoacylglycerol)phosphate in breast cancer / $c AL. Berg, MR. Showalter, N. Kosaisawe, M. Hu, NC. Stephens, M. Sa, H. Heil, N. Castro, JJ. Chen, K. VanderVorst, MR. Wheeler, Z. Rabow, T. Cajka, J. Albeck, O. Fiehn, KL. Carraway
520    9_
$a Bis(monoacylglycero)phosphates (BMPs), a class of lipids highly enriched within endolysosomal organelles, are key components of the lysosomal intraluminal vesicles responsible for activating sphingolipid catabolic enzymes. While BMPs are understudied relative to other phospholipids, recent reports associate BMP dysregulation with a variety of pathological states including neurodegenerative diseases and lysosomal storage disorders. Since the dramatic lysosomal remodeling characteristic of cellular transformation could impact BMP abundance and function, we employed untargeted lipidomics approaches to identify and quantify BMP species in several in vitro and in vivo models of breast cancer and comparative non-transformed cells and tissues. We observed lower BMP levels within transformed cells relative to normal cells, and consistent enrichment of docosahexaenoic acid (22:6) fatty acyl chain-containing BMP species in both human- and mouse-derived mammary tumorigenesis models. Our functional analysis points to a working model whereby 22:6 BMPs serve as reactive oxygen species scavengers in tumor cells, protecting lysosomes from oxidant-induced lysosomal membrane permeabilization. Our findings suggest that breast tumor cells might divert polyunsaturated fatty acids into BMP lipids as part of an adaptive response to protect their lysosomes from elevated reactive oxygen species levels, and raise the possibility that BMP-mediated lysosomal protection is a tumor-specific vulnerability that may be exploited therapeutically.
650    _2
$a zvířata $7 D000818
650    _2
$a myši $7 D051379
650    _2
$a lidé $7 D006801
650    _2
$a ženské pohlaví $7 D005260
650    12
$a kyseliny dokosahexaenové $7 D004281
650    12
$a nádory prsu $x patologie $7 D001943
650    _2
$a fosfáty $x metabolismus $7 D010710
650    _2
$a reaktivní formy kyslíku $x metabolismus $7 D017382
650    _2
$a lysofosfolipidy $x metabolismus $7 D008246
650    _2
$a lyzozomy $x metabolismus $7 D008247
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
700    1_
$a Showalter, Megan R $u West Coast Metabolomics Center, UC Davis Genome Center, University of California Davis, Davis, CA, USA
700    1_
$a Kosaisawe, Nont $u Department of Molecular and Cellular Biology, University of California Davis, Davis, CA, USA
700    1_
$a Hu, Michelle $u Department of Biochemistry and Molecular Medicine and UC Davis Comprehensive Cancer Center, University of California Davis School of Medicine, Sacramento, CA, USA
700    1_
$a Stephens, Nathanial C $u West Coast Metabolomics Center, UC Davis Genome Center, University of California Davis, Davis, CA, USA
700    1_
$a Sa, Michael $u West Coast Metabolomics Center, UC Davis Genome Center, University of California Davis, Davis, CA, USA
700    1_
$a Heil, Hailey $u West Coast Metabolomics Center, UC Davis Genome Center, University of California Davis, Davis, CA, USA
700    1_
$a Castro, Noemi $u Department of Biochemistry and Molecular Medicine and UC Davis Comprehensive Cancer Center, University of California Davis School of Medicine, Sacramento, CA, USA
700    1_
$a Chen, Jenny J $u Department of Biochemistry and Molecular Medicine and UC Davis Comprehensive Cancer Center, University of California Davis School of Medicine, Sacramento, CA, USA
700    1_
$a VanderVorst, Kacey $u Department of Biochemistry and Molecular Medicine and UC Davis Comprehensive Cancer Center, University of California Davis School of Medicine, Sacramento, CA, USA
700    1_
$a Wheeler, Madelyn R $u Department of Biochemistry and Molecular Medicine and UC Davis Comprehensive Cancer Center, University of California Davis School of Medicine, Sacramento, CA, USA
700    1_
$a Rabow, Zachary $u West Coast Metabolomics Center, UC Davis Genome Center, University of California Davis, Davis, CA, USA
700    1_
$a Cajka, Tomas $u West Coast Metabolomics Center, UC Davis Genome Center, University of California Davis, Davis, CA, USA; Institute of Physiology of the Czech Academy of Sciences, Prague, 14200, Czech Republic
700    1_
$a Albeck, John $u Department of Molecular and Cellular Biology, University of California Davis, Davis, CA, USA
700    1_
$a Fiehn, Oliver $u West Coast Metabolomics Center, UC Davis Genome Center, University of California Davis, Davis, CA, USA
700    1_
$a Carraway, Kermit L $u Department of Biochemistry and Molecular Medicine and UC Davis Comprehensive Cancer Center, University of California Davis School of Medicine, Sacramento, CA, USA. Electronic address: klcarraway@ucdavis.edu
773    0_
$w MED00001044 $t Cancer letters $x 1872-7980 $g Roč. 557, č. - (2023), s. 216090
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36773796 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230418 $b ABA008
991    __
$a 20230425140838 $b ABA008
999    __
$a ok $b bmc $g 1924424 $s 1189945
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 557 $c - $d 216090 $e 20230210 $i 1872-7980 $m Cancer letters $n Cancer Lett $x MED00001044
LZP    __
$a Pubmed-20230418

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...